bottlenecks
Bottlenecks
The constraints slowing diagnosis, trials, and care, with the ideas that could break each one.
The pipeline and where it clogs
4 bottlenecks · 3 ideas aimed at them
criticalmajormoderate
- 1Understand the disease1 bottlenecks · 0 ideas
- 2Prevent and find early1 bottlenecks · 1 ideas
- 3Test in people1 bottlenecks · 1 ideas
- 4Approve and make0 bottlenecks · 0 ideas
- 5Deliver care1 bottlenecks · 1 critical · 1 ideas
- 6Learn from every patient0 bottlenecks · 0 ideas
- 7Pay for the right things0 bottlenecks · 0 ideas
- 8People and culture0 bottlenecks · 0 ideas
Numbers on the right of each bottleneck are ideas in the corpus that attack it. Hover anything for the one-line version.
4 bottlenecks
| Technologies that relieve it | ||||
|---|---|---|---|---|
Unpaid care as the hidden delivery system Most day-to-day dementia care is unpaid. Medicines and scans fail in practice if one person is carrying every task alone. | 1 | none | ||
Late and uneven diagnosis Many people receive a dementia diagnosis late, or never receive a subtype. That blocks both care planning and trial entry. | 1 | none | ||
Trial populations that skip mixed disease Antibody trials largely enrolled people with biomarker-supported Alzheimer’s disease and excluded much mixed, vascular, and diverse disease. | 1 | none | ||
Wrong-subtype treatment Lewy body, vascular, and frontotemporal dementia are still treated as if they were typical Alzheimer’s disease, which can add harm. | 0 | none |